The "Potential therapeutic strategy to treat substance-abuse-related disorders" session was chaired by Dr. Sulie L. Chang, director of NeuroImmune Phamacology at Seton Hall University. The four presenters were: Dr Wenzhe Ho (Miniway to stop HIV/HCV), Dr Ru-Band Lu (Low dose of memantine in the treatment of opioid dependence in human), Dr Ping Zhang (Treatment of alcohol-related disorders: Learning from stem/progenitor cells), and Dr Yun-Hsiang Chen (Treatment of methamphetamine abuse: An antibody-based immunotherapy approach). Copyright © 2013, Food and Drug Administration, Taiwan.
"Potential therapeutic strategy to treat substance abuse related disorders,"
Journal of Food and Drug Analysis: Vol. 21
, Article 44.
Available at: https://doi.org/10.1016/j.jfda.2013.09.028
Creative Commons License
This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 4.0 License.